Check the admission tab for the selection criteria.
Apply via studielink. Make sure you include all required documents that are mentioned.
On the basis of your application we may invite you for a (Skype) interview.
Erasmus MC medical students
Selected Erasmus MC students of Medicine have the opportunity to follow the whole year 1 of the MSc Molecular Medicine program, followed by the master of Medicine. You are advised to participate in a research-oriented minor during bachelor 3 of the medical curriculum (minor biomedical research in practice).
You will be exempt from the medical master electives (Keuze-onderzoek, 30 EC points), provided that you successfully finish your first research project within the MSc Molecular Medicine Program.
Year 2 of the MSc Molecular Medicine Program, a full-year research project leading up to the MSc thesis, is performed after finishing Medicine. Upon graduation, you may get the chance to continue a scientific career as a PhD student.
Other BSc graduates
Prospective international or Dutch students should have a bachelor's degree or an equivalent level of training in the life sciences, such as biology, biomedicine, medicine, or related fields.
Dutch HBO-BML graduates
BASc students in Biomedical Lab Techniques, from the Hogeschool Rotterdam or other relevant higher vocational training program (HBO) within The Netherlands, may apply. In addition to the general selection criteria, a letter of reference from your mentor is required and a written entrance examination.
MSc students in Biotechnology and Molecular Life Sciences from Wageningen University are offered the possibility to specialize in ‘Molecular Medicine’:
WUR course modules / 60 ECTS:
XEU-80336 Thesis Molecular Medicine part A
XEU-80324 Thesis Molecular Medicine part B
These students follow the complete 2nd year curriculum of the MSc Molecular Medicine program, conducting a full-year research project and writing the MSc Thesis in Rotterdam. WUR - MBT students will graduate in Wageningen. Interested students can contact the MSc Biotechnology coordinator, Dr Sonja Isken.